BD (company)

Parts of this article (those related to documentation) need to be updated. Please help update this article to reflect recent events or newly available information. (January 2022)

Becton, Dickinson and Company

Trade name	BD
Company type	Public
Traded as	NYSE: BDX S&P 500 component
Industry	Medical equipment, Consulting
Founded	1897; 127 years ago (1897) in East Rutherford, New Jersey
Founders	Maxwell Becton Fairleigh S. Dickinson
Headquarters	BD Headquarters Franklin Lakes, New Jersey , U.S.
Area served	Worldwide
Key people	Tom Polen[1] (Chairman, CEO and President) Christopher R. Reidy[2] (Executive Vice President and CAO) Christopher DelOrefice[3] (Executive Vice President and CFO)
Revenue	US$20.248 billion (Fiscal Year Ended September 30, 2021)
Operating income	US$2.799 billion (Fiscal Year Ended September 30, 2021)
Net income	US$2.002 billion (Fiscal Year Ended September 30, 2021)
Total assets	US$53.866 billion (Fiscal Year Ended September 30, 2021)
Total equity	US$23.677 billion (Fiscal Year Ended September 30, 2021)
Number of employees	≈ 75,000 (September 2021)
Divisions	BD Interventional BD Life Sciences BD Medical
Website	bd.com
Footnotes / references Financials as of September 30, 2021[update][4]

41°00′57″N 74°12′36″W / 41.015834°N 74.210136°W / 41.015834; -74.210136

Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.^[5]

BD is ranked #211 in the 2024 Fortune 500 list^[6] based on its revenues for the fiscal year ending September 30, 2023.